Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain

Saved in:
Bibliographic Details
Published in:Multiple sclerosis and related disorders Vol. 42; p. 102185
Main Authors: Montero-Escribano, Paloma, Matías-Guiu, Jorge, Gómez-Iglesias, Patricia, Porta-Etessam, Jesús, Pytel, Vanesa, Matias-Guiu, Jordi A.
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01.07.2020
Subjects:
Antibodies, Monoclonal, Humanized
Betacoronavirus
Coronavirus Infections
COVID-19
Humans
Letter to the Editor
Multiple Sclerosis
Neurology
Pandemics
Pneumonia, Viral
SARS-CoV-2
Spain
Spain
ISSN:2211-0348, 2211-0356, 2211-0356
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
ArticleNumber 102185
Author Gómez-Iglesias, Patricia
Matías-Guiu, Jorge
Montero-Escribano, Paloma
Porta-Etessam, Jesús
Pytel, Vanesa
Matias-Guiu, Jordi A.
Author_xml – sequence: 1
  givenname: Paloma
  surname: Montero-Escribano
  fullname: Montero-Escribano, Paloma
– sequence: 2
  givenname: Jorge
  orcidid: 0000-0001-8162-9043
  surname: Matías-Guiu
  fullname: Matías-Guiu, Jorge
– sequence: 3
  givenname: Patricia
  surname: Gómez-Iglesias
  fullname: Gómez-Iglesias, Patricia
– sequence: 4
  givenname: Jesús
  surname: Porta-Etessam
  fullname: Porta-Etessam, Jesús
– sequence: 5
  givenname: Vanesa
  orcidid: 0000-0002-2518-338X
  surname: Pytel
  fullname: Pytel, Vanesa
– sequence: 6
  givenname: Jordi A.
  orcidid: 0000-0001-5520-2708
  surname: Matias-Guiu
  fullname: Matias-Guiu, Jordi A.
  email: jordimatiasguiu@hotmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32408147$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1v1DAUjFARLaW_AAn5yIEs_kicBESl1ZaPSkU9FLhar_Zb8OLYwU4q9d_jdMsKKqG1D7bsmXlPM-9pceCDx6J4zuiCUSZfbxZ9gmgWnPL5hbO2flQccc5YSUUtD3b3qj0sTlLa0LxkzSrJnhSHgle0ZVVzVKSlH225OuOUgDdkdfnt_KxkHbGe9JMb7eCQJO0whmTTHSSigxENMTaFaDCmN2RJNKSMw2gxkbAmkpIBRot-TGQdQ08-g4nWvCJXA1j_rHi8Bpfw5P48Lr5-eP9l9am8uPx4vlpelLqWcixr1vEOmla2tGKC18x0RhqKomKAHdZwXRktoRWCA0PdNMLUskOQspW1ABDHxelWd5iuezQ6txPBqSHaHuKtCmDVvz_e_lDfw41qOK1kJbLAy3uBGH5NmEbV26TROfAYpqSyi3nXLesy9MXftXZF_jidAWIL0NnKFHG9gzCq5kjVRt1FquZI1TbSzOoesLQds7Nhbti6Pdx3Wy5mj28sRpV0jkSjsRH1qEywe_inD_jaWW81uJ94i2kTpuhzfIqpxBVVV_PAzfPGqaBcstm-t_8X2Fv-N2Pk47Y
CitedBy_id crossref_primary_10_1016_j_clineuro_2024_108160
crossref_primary_10_1016_j_msard_2024_105940
crossref_primary_10_1111_ene_14329
crossref_primary_10_3390_vaccines12121418
crossref_primary_10_1016_j_jinf_2021_05_024
crossref_primary_10_3390_vaccines10060904
crossref_primary_10_1002_acn3_51342
crossref_primary_10_1212_NXI_0000000000001024
crossref_primary_10_1002_jmv_26319
crossref_primary_10_1016_j_jacig_2023_100091
crossref_primary_10_3389_fimmu_2021_708848
crossref_primary_10_1002_eji_202149574
crossref_primary_10_1016_j_msard_2020_102516
crossref_primary_10_4103_ijpvm_IJPVM_480_20
crossref_primary_10_1038_s41423_021_00743_3
crossref_primary_10_1111_ene_14690
crossref_primary_10_1093_ofid_ofab176
crossref_primary_10_1016_j_msard_2020_102276
crossref_primary_10_1016_j_msard_2020_102353
crossref_primary_10_1016_j_neurol_2020_08_001
crossref_primary_10_1016_j_msard_2021_103371
crossref_primary_10_1016_S2213_2600_21_00218_6
crossref_primary_10_1093_cid_ciaa863
crossref_primary_10_1016_j_msard_2021_103217
crossref_primary_10_3389_fimmu_2022_904686
crossref_primary_10_3389_fimmu_2022_835104
crossref_primary_10_1016_j_msard_2021_102800
crossref_primary_10_1007_s00415_020_10015_1
crossref_primary_10_1007_s11926_021_01037_3
crossref_primary_10_1016_j_msard_2021_102968
crossref_primary_10_1016_j_nrleng_2021_03_002
crossref_primary_10_1016_j_msard_2020_102222
crossref_primary_10_1016_j_jbc_2023_103035
crossref_primary_10_3389_fimmu_2022_993754
crossref_primary_10_3390_biom11091372
crossref_primary_10_3390_jcm12175460
crossref_primary_10_1016_j_jcv_2022_105098
crossref_primary_10_1007_s10875_022_01313_6
crossref_primary_10_1002_ana_26028
crossref_primary_10_1186_s12883_021_02218_4
crossref_primary_10_3390_vaccines10071103
crossref_primary_10_1016_j_cell_2021_01_007
crossref_primary_10_1016_j_msard_2021_103263
crossref_primary_10_1159_000530764
crossref_primary_10_1111_bjh_17266
crossref_primary_10_1212_NXI_0000000000001046
crossref_primary_10_1016_j_jneuroim_2020_577283
crossref_primary_10_12890_2022_003502
crossref_primary_10_1007_s00011_021_01446_1
crossref_primary_10_3389_fneur_2022_843081
crossref_primary_10_3390_vaccines10030442
crossref_primary_10_1016_j_msard_2020_102259
crossref_primary_10_1093_oxfimm_iqac005
crossref_primary_10_1016_j_msard_2020_102452
crossref_primary_10_1016_j_msard_2020_102297
crossref_primary_10_1016_j_msard_2020_102372
crossref_primary_10_1126_sciimmunol_abl5344
crossref_primary_10_1097_YCO_0000000000000688
crossref_primary_10_1111_cei_13495
crossref_primary_10_1007_s00415_020_10362_z
crossref_primary_10_1007_s00415_020_10112_1
crossref_primary_10_1007_s40263_021_00843_8
crossref_primary_10_3389_fimmu_2022_836495
crossref_primary_10_1016_j_msard_2021_103358
crossref_primary_10_1007_s40263_020_00756_y
crossref_primary_10_1016_j_msard_2021_103437
crossref_primary_10_1136_jnnp_2021_328197
crossref_primary_10_1016_j_msard_2021_103359
crossref_primary_10_3389_fimmu_2023_1061255
crossref_primary_10_3390_diseases9020032
crossref_primary_10_1212_NXI_0000000000001035
crossref_primary_10_1002_acr2_11204
crossref_primary_10_1016_j_msard_2020_102725
crossref_primary_10_3390_jcm9124066
crossref_primary_10_1002_jmv_26279
crossref_primary_10_3390_vaccines9070773
crossref_primary_10_3390_jcm9124067
crossref_primary_10_1016_j_msard_2020_102442
crossref_primary_10_1007_s13760_022_02125_6
crossref_primary_10_1007_s13311_021_01008_7
crossref_primary_10_1016_j_cell_2022_07_002
crossref_primary_10_1177_1352458520942198
Cites_doi 10.1016/S1474-4422(20)30147-2
10.1016/j.nrl.2020.03.001
10.1016/j.jaci.2020.04.013
10.1111/pai.13263
10.1126/science.7403860
10.1016/j.msard.2020.102135
10.1016/j.msard.2020.102073
10.1016/j.msard.2020.102120
10.1016/S0140-6736(20)30154-9
ContentType Journal Article
Copyright 2020 Elsevier B.V.
Elsevier B.V.
2020 Elsevier B.V. All rights reserved. 2020 Elsevier B.V.
Copyright_xml – notice: 2020 Elsevier B.V.
– notice: Elsevier B.V.
– notice: 2020 Elsevier B.V. All rights reserved. 2020 Elsevier B.V.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.msard.2020.102185
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2211-0356
EndPage 102185
ExternalDocumentID PMC7204643
32408147
10_1016_j_msard_2020_102185
S2211034820302613
1_s2_0_S2211034820302613
Genre Letter
Comment
Commentary
Correspondence
GeographicLocations Spain
GeographicLocations_xml – name: Spain
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1P~
1~.
1~5
4.4
457
4G.
53G
5VS
7-5
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABGSF
ABJNI
ABMAC
ABMZM
ABTEW
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGWIK
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
EBS
EFJIC
EFKBS
EFLBG
EJD
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HZ~
KOM
M41
MO0
MOBAO
O-L
O9-
OAUVE
OP~
P-8
P-9
PC.
Q38
ROL
SDF
SEL
SPCBC
SSH
SSN
SSU
SSZ
T5K
Z5R
~G-
~HD
AACTN
AFKWA
AJOXV
AMFUW
RIG
AADPK
AAIAV
ABLVK
ABYKQ
AJBFU
DOVZS
LCYCR
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c566t-51929a78680413251d9d6d0e341ae9e5ab4dc6a8332a1ec773d569ea668653aa3
ISICitedReferencesCount 94
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000544068100007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2211-0348
2211-0356
IngestDate Tue Sep 30 15:37:05 EDT 2025
Sun Sep 28 11:42:04 EDT 2025
Thu Apr 03 07:00:13 EDT 2025
Tue Nov 18 22:33:05 EST 2025
Wed Nov 05 20:53:14 EST 2025
Fri Feb 23 02:43:43 EST 2024
Sun Feb 23 10:19:57 EST 2025
Tue Oct 14 19:31:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Language English
License Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c566t-51929a78680413251d9d6d0e341ae9e5ab4dc6a8332a1ec773d569ea668653aa3
Notes SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ObjectType-Commentary-2
content type line 23
ORCID 0000-0001-8162-9043
0000-0001-5520-2708
0000-0002-2518-338X
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7204643
PMID 32408147
PQID 2404045819
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7204643
proquest_miscellaneous_2404045819
pubmed_primary_32408147
crossref_primary_10_1016_j_msard_2020_102185
crossref_citationtrail_10_1016_j_msard_2020_102185
elsevier_sciencedirect_doi_10_1016_j_msard_2020_102185
elsevier_clinicalkeyesjournals_1_s2_0_S2211034820302613
elsevier_clinicalkey_doi_10_1016_j_msard_2020_102185
PublicationCentury 2000
PublicationDate 2020-07-01
PublicationDateYYYYMMDD 2020-07-01
PublicationDate_xml – month: 07
  year: 2020
  text: 2020-07-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Multiple sclerosis and related disorders
PublicationTitleAlternate Mult Scler Relat Disord
PublicationYear 2020
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Burks J, DeVald B, Jankovsky L, Gerdes J (bib0001) 1980; 209
Giovannoni (bib0004) 2020; 41
Matías-Guiu, Porta-Etessam, Lopez-Valdes, Garcia-Morales, Guerrero-Solá, Matias-Guiu (bib0006) 2020
Giovannoni, Hawkes, Lechner-Scott, Levy, Waubant, Gold (bib0005) 2020; 39
Novi, Mikulska, Briano, Toscanini, Tazza, Uccelli (bib0008) 2020; 42
Chan, Yuan, Kok, To, Chu, Yang (bib0002) 2020; 395
Matías-Guiu, Gomez-Pinedo, Montero-Escribano, Gomez-Iglesias, Porta-Etessam, Matias-Guiu (bib0007) 2020; 35
Quinti, Lougaris, Milito, Cinetto, Pecoraro, Mezzaroma (bib0009) 2020
Sormani (bib0011) 2020
Soresina, Moratto, Chiarini, Paolillo, Baresi, Focà (bib0010) 2020
Giovannoni (10.1016/j.msard.2020.102185_bib0004) 2020; 41
Quinti (10.1016/j.msard.2020.102185_bib0009) 2020
Chan (10.1016/j.msard.2020.102185_bib0002) 2020; 395
Matías-Guiu (10.1016/j.msard.2020.102185_bib0007) 2020; 35
Novi (10.1016/j.msard.2020.102185_bib0008) 2020; 42
Soresina (10.1016/j.msard.2020.102185_bib0010) 2020
Burks J (10.1016/j.msard.2020.102185_bib0001) 1980; 209
Matías-Guiu (10.1016/j.msard.2020.102185_bib0006) 2020
Giovannoni (10.1016/j.msard.2020.102185_bib0005) 2020; 39
Sormani (10.1016/j.msard.2020.102185_bib0011) 2020
32315980 - Mult Scler Relat Disord. 2020 Jul;42:102120
References_xml – volume: 209
  start-page: 933
  year: 1980
  end-page: 934
  ident: bib0001
  article-title: Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients
  publication-title: Science
– volume: 395
  start-page: 514
  year: 2020
  end-page: 523
  ident: bib0002
  article-title: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
  publication-title: Lancet
– volume: 39
  year: 2020
  ident: bib0005
  article-title: The COVID-19 pandemic and the use of MS disease-modifying therapies
  publication-title: Mult. Scler. Relat. Disord.
– year: 2020
  ident: bib0009
  article-title: A posible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia
  publication-title: J. Allergy Clin. Immunol.
– year: 2020
  ident: bib0010
  article-title: Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover
  publication-title: Pediatr. Allergy Immunol.
– year: 2020
  ident: bib0006
  article-title: Management of neurological care during the COVID-19 pandemic
  publication-title: Neurologia
– volume: 35
  start-page: 170
  year: 2020
  end-page: 175
  ident: bib0007
  article-title: Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
  publication-title: Neurologia
– volume: 42
  year: 2020
  ident: bib0008
  article-title: COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
  publication-title: Mult. Scler. Relat. Disord.
– volume: 41
  year: 2020
  ident: bib0004
  article-title: Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
  publication-title: Mult. Scler. Relat. Disord.
– year: 2020
  ident: bib0011
  article-title: An Italian programme for COVID-19 infection in multiple sclerosis
  publication-title: Lancet Neurol.
– year: 2020
  ident: 10.1016/j.msard.2020.102185_bib0011
  article-title: An Italian programme for COVID-19 infection in multiple sclerosis
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(20)30147-2
– volume: 35
  start-page: 170
  year: 2020
  ident: 10.1016/j.msard.2020.102185_bib0007
  article-title: Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
  publication-title: Neurologia
  doi: 10.1016/j.nrl.2020.03.001
– year: 2020
  ident: 10.1016/j.msard.2020.102185_bib0009
  article-title: A posible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia
  publication-title: J. Allergy Clin. Immunol.
  doi: 10.1016/j.jaci.2020.04.013
– year: 2020
  ident: 10.1016/j.msard.2020.102185_bib0010
  article-title: Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover
  publication-title: Pediatr. Allergy Immunol.
  doi: 10.1111/pai.13263
– volume: 209
  start-page: 933
  year: 1980
  ident: 10.1016/j.msard.2020.102185_bib0001
  article-title: Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients
  publication-title: Science
  doi: 10.1126/science.7403860
– volume: 41
  year: 2020
  ident: 10.1016/j.msard.2020.102185_bib0004
  article-title: Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
  publication-title: Mult. Scler. Relat. Disord.
  doi: 10.1016/j.msard.2020.102135
– volume: 39
  year: 2020
  ident: 10.1016/j.msard.2020.102185_bib0005
  article-title: The COVID-19 pandemic and the use of MS disease-modifying therapies
  publication-title: Mult. Scler. Relat. Disord.
  doi: 10.1016/j.msard.2020.102073
– year: 2020
  ident: 10.1016/j.msard.2020.102185_bib0006
  article-title: Management of neurological care during the COVID-19 pandemic
  publication-title: Neurologia
– volume: 42
  year: 2020
  ident: 10.1016/j.msard.2020.102185_bib0008
  article-title: COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
  publication-title: Mult. Scler. Relat. Disord.
  doi: 10.1016/j.msard.2020.102120
– volume: 395
  start-page: 514
  year: 2020
  ident: 10.1016/j.msard.2020.102185_bib0002
  article-title: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30154-9
– reference: 32315980 - Mult Scler Relat Disord. 2020 Jul;42:102120
SSID ssj0000651461
Score 2.505149
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 102185
SubjectTerms Antibodies, Monoclonal, Humanized
Betacoronavirus
Coronavirus Infections
COVID-19
Humans
Letter to the Editor
Multiple Sclerosis
Neurology
Pandemics
Pneumonia, Viral
SARS-CoV-2
Spain
Title Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2211034820302613
https://www.clinicalkey.es/playcontent/1-s2.0-S2211034820302613
https://dx.doi.org/10.1016/j.msard.2020.102185
https://www.ncbi.nlm.nih.gov/pubmed/32408147
https://www.proquest.com/docview/2404045819
https://pubmed.ncbi.nlm.nih.gov/PMC7204643
Volume 42
WOSCitedRecordID wos000544068100007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 2211-0356
  dateEnd: 20210531
  omitProxy: false
  ssIdentifier: ssj0000651461
  issn: 2211-0348
  databaseCode: AIEXJ
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELZ6oKoviJvlqIzEG3WVaxOHt6VdShEtSBS0b5bjeEuqbXa12a0q_iJ_ihk7do-lpTzwEq0SH9nMF894MvMNIa-7KpC85JIVXGUsiUrNeBoqxmPQVrEqyzAxicKfsoMDPhjkX5aWfrlcmNNRVtf87Cyf_FdRwzkQNqbO_oO4_aBwAn6D0OEIYofjrQTfq2cV296JAvNdYPvz970dFubo1_DBgw10Ae1YWX5mk84CdmfZEnE2NltdgX57g3dsaWnTwHGwNjYnZV9iZXbjPZ3Ilr_blYa65URe2kiRNR2zPq5hhTTVwMG2HY3Plca-nJlv-juyYbvzam49_9Mjj8tdvPwuPtE_2d7RSDeVvFCCoPLjmMhZ1kcDu00Qh3USe_YuOUBgt-uCZUF_mYUyitDNG1uCcreqW86udlnG-uW2MtCCxrDOi-OtkwbeyC0cf2uxNTz3yYnBC_IX8tCShF4h6naXlslqlHVzWGJXe3v9wUfv8gNrD6uoO-4rE2W4MO06WXMDXWcqLW6Frkb0XjCRDu-Ru-3ehvYsJu-TJV0_IGv7bfTGQ9J4aFKAA3XQpFVNHTSpR4xp0iKGesS8pT2KwKQWmHQ8pGlAHTApApNaYG5SA8tH5Nv7_uH2B9YW_WAKdhYzBjuKKJcZT5EYKwbru8zLtAw0WFtS57ori6RUqeRxHMlQqyyLy26aa5mmPO3GUsaPyUo9rvVTQlUWDrMCVFZRRIkCUzvTfFjGEkzaQskk7pDIPV-hWkZ8LMwyEi708VgY-QiUj7Dy6ZBN32liCWFubp44wQmX6wzaWQD8bu6W_ambbtqFphGhaCIRiK8I_gAZqkBbR2Cbd0jqe7ZGtDWO_z7lK4crASoGvxvKWo_njQA4JhhPEeYd8sTizP91h1W44UsI9A2Qvv7ylbr6YWjssTwW7IeeXTvmc7J-_r6_ICuz6Vy_JHfU6axqphtkORvwjfYd-w04xgbg
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-CD20+and+COVID-19+in+multiple+sclerosis+and+related+disorders%3A+A+case+series+of+60+patients+from+Madrid%2C+Spain&rft.jtitle=Multiple+sclerosis+and+related+disorders&rft.au=Montero-Escribano%2C+Paloma&rft.au=Mat%C3%ADas-Guiu%2C+Jorge&rft.au=G%C3%B3mez-Iglesias%2C+Patricia&rft.au=Porta-Etessam%2C+Jes%C3%BAs&rft.date=2020-07-01&rft.eissn=2211-0356&rft.volume=42&rft.spage=102185&rft_id=info:doi/10.1016%2Fj.msard.2020.102185&rft_id=info%3Apmid%2F32408147&rft.externalDocID=32408147
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F22110348%2FS2211034820X00046%2Fcov150h.gif